A new Alzheimer’s therapy is approved in China, delivering a surprise for the field but also questions

Chinese regulators have granted conditional approval to an Alzheimer’s drug that is derived from seaweed, potentially shaking up the field after years of clinical failures involving experimental therapies from major drug companies. (source: statnews.com)

(No Ratings Yet)

Loading...